Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.52
-0.03 (-0.21%)
Mar 4, 2026, 11:28 AM EST - Market open
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
$807,210
Profits / Employee
-$1,165,062
Market Cap
1.83B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Recursion Pharmaceuticals | 800 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 291 |
| Celldex Therapeutics | 186 |
| Soleno Therapeutics | 152 |
MESO News
- 5 days ago - Mesoblast (MESO) Reports Significant Miss in 1H Earnings - GuruFocus
- 5 days ago - Mesoblast misses H1 estimates - Seeking Alpha
- 5 days ago - Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Half Year 2026 Mesoblast Ltd Earnings Presentation Transcript - GuruFocus
- 5 days ago - Ryoncil® Profits Underpinning Substantial Growth Pipeline - GlobeNewsWire
- 7 days ago - What's Next: Mesoblast's Earnings Preview - Benzinga
- 12 days ago - Mesoblast Financial Results and Corporate Update Webcast - GlobeNewsWire
- 20 days ago - Mesoblast Touts High Survival Rates For FDA-Approved Cell Therapy - Benzinga